Media coverage
1Media coverage
Title Bristol Myers Squibb : ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% of Post-Liver Transplant Patients with Hepatitis C and Up to 94% of Hepatitis C Patients with Cirrhosis (Child-Pugh Class A or B) Media name/outlet 4 Traders Country United States Date 4/25/15 Persons Fred Poordad